Here are relevant reports on : live-event-technology-market
-
Event Management Software Market by Software (Event Planning & Operations, Event Marketing, Virtual & Hybrid Platform, and Analytics, AI & Event Intelligence), Event Type (Product Launches, Corporate Meetings, and Conferences) - Global Forecast to 2031
The global event management software market is expanding rapidly, with a projected market size rising from about USD 18.6 billion in 2026 to USD 36.8 billion by 2031, reflecting a CAGR of 14.6%. The major players in the event management software market include Cvent (US), Eventbrite (US), Zoom (US), Stova (US), RingCentral (US), Momentus Technologies (US), Bizzabo (US), Whova (US), Zoho(US), and Cisco (US).
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
IT Operations Analytics (ITOA) Market by Technology (Prescriptive analytics, Predictive analytics), Application (Root Cause Analysis, Application Performance Monitoring (APM), Security & Event Management, Network Management, BPM) - Global Forecast to 2029
The global market for the IT operations analytics market is projected to reach USD 127.4 billion in 2029, at a CAGR of 36.6% during the forecast period. The major IT operations analytics solutions and service providers include Cisco (US), Broadcom (US), IBM (US), Oracle (US), Microsoft (US), OpenText (Canada), Hitachi (Japan), Dynatrace (US), SolarWinds (US), BMC Software (US), NetApp (US), Elastic (US), Nexthink (Switzerland), HCL Technologies (India), New Relic (US), ServiceNow (US), Dell Technologies (US), HPE (US), Cloud Software Group (US), Veritas Technologies (US), BigPanda (US), ExtraHop Networks (US), Squadcast (US), ScienceLogic (US), Apica (Sweden), Diamanti (US), MCG (Denmark), Evolven (US), XPLG (US), HEAL Software (US), Sumo Logic (US), Devo (US), meshIQ (US), and CloudFabrix (US). These companies have used both organic and inorganic growth strategies such as product launches, acquisitions, and partnerships to strengthen their position in the IT operations analytics market.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
US Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), and End User (Hospitals, Clinics) – Forecast to 2031
The US veterinary vaccines market, valued at USD4.39 billion in 2025, stood at USD4.67 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2031, culminating in a forecasted valuation of USD6.50 billion by the end of the period. This growth is attributed to the increasing awareness regarding animal health as well as the rising pet population and pet ownership. Other emerging trends affecting the growth of this segment are government initiatives to improve the health of animals and increased adoption of pet coverage.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral) - Forecast to 2030
The Asia Pacific Vaccines market, valued at USD 9.46 billion in 2024, stood at USD 9.89 billion in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2030, culminating in a forecasted valuation of USD14.57 billion by the end of the period. The market is expanding quickly, driven by a rise in vaccine development and commercialization, heightened infectious disease rates, and the extensive use of preventive vaccines.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Europe Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral) - Forecast to 2030
The Europe vaccines market, valued at US$10.53 billion in 2024, stood at US$9.97 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2025 to 2030, culminating in a forecasted valuation of US$13.74 billion by the end of the period. The vaccines market is growing due to fast global developments and the commercialization of vaccines, rising rates of infectious diseases, which require preventive measures, and government initiatives to encourage vaccinations, immunization programs, advancements, and investments in new vaccines against various diseases.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Metaverse in Entertainment Market by Offering (Hardware, Software, Professional Services), Technology (XR, AI, Blockchain, Cloud & Edge), Entertainment Type (Gaming, Live Events, Sports, Music, Films & TV), and Region - Global Forecast to 2032
The global metaverse in entertainment market size will grow to USD 121.96 billion by 2032 from USD 30.6 billion in 2026, at a CAGR of 25.9% during the forecast period. Some of the key players operating in the metaverse in entertainment market are Roblox (US), Epic Games (US), Meta (US), Microsoft (US), Take-Two Interactive (US), Electronic Arts (US), Apple (US), Sony Group Corporation (Japan), Google (US), Unity Technologies (US), Deloitte (UK), Tata Consultancy Services (TCS) (India), DPVR (China), Capgemini (France), Pimax (China), Rokid (China), Magic Leap (US), Tencent (China), NetEase (China), Valve (US), HTC Corporation (Taiwan), TCL (China), Samsung Electronics (South Korea), ByteDance (China), XREAL (China), Decentraland (Argentina), Niantic (US), VRChat (US), The Sandbox (Hong Kong), Uplandme, Inc. (US), and Play For Dream (China).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Military Simulation and Training Market by Application (Army, Aviation, Naval), Type (Live, Virtual, Constructive), Platform (Land, Maritime, Airborne), Solution, Environment (Synthetic, Gaming), Technology, and Region - Global Forecast
The Military Simulation and Training market size is projected to reach USD 12.2 billion by 2027, at a CAGR of 5.6% during the forecast period. This region is expected to lead the market from 2021 to 2026, owing to increased investments and the adoption of advanced military simulators for all the platforms by countries in this region. The presence of prominent manufacturers and integrators of these Military Simulation and Training, including Lockheed Martin (US), Northrop Grumman (US), L3Harris Technologies, Inc. (US), and Raytheon Technologies (US), is also expected drive the market in the region over the forecast period.
- Published: April 2022
- Price: $ 4950
- TOC Available:
-
Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral)-Global Forecast to 2030
The global vaccines market (excluding COVID-19 vaccines), valued at USD 49.59 billion in 2024, stood at USD 47.65 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of USD 67.91 billion by the end of the period.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Vaccines Market by Type (Porcine, Poultry, Bovine, Ruminant, Canine, Feline, Aquaculture), Technology (Live Attenuated, Inactivated, Toxoid, Recombinant), Route of Administration (Subcutaneous, Oral), End User - Global Forecast to 2031
The global veterinary vaccines market is projected to reach USD 18.46 billion by 2031, growing at a CAGR of 7.2% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
North America Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral) - Forecast to 2030
The North America vaccines market, valued at US$25.95 billion in 2024, stood at US$25.29 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$35.68 billion by the end of the period. The vaccines market is growing rapidly, driven by swift global vaccine development and commercialization, higher rates of infectious diseases necessitating preventive vaccines, expanded immunization initiatives, innovations in vaccine technology, and increased government funding and investments for novel vaccines against diverse diseases.
- Published: August 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
